Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19
<h4>Background</h4> SARS-CoV-2 invades human cells and leads to COVID-19 by direct associating with angiotensin converting enzyme 2 (ACE2) receptors, the level of which may be increased by treatment with angiotensin-converting enzyme inhibitors (ACEIs) and/or angiotensin receptor blocker...
Main Authors: | Nancy Xurui Huang, Qi Yuan, Fang Fang, Bryan P. Yan, John E. Sanderson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836310/?tool=EBI |
Similar Items
-
Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19.
by: Nancy Xurui Huang, et al.
Published: (2023-01-01) -
Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
by: S Ravitej, et al.
Published: (2022-11-01) -
Effects of ACEI and ARB on COVID-19 patients: A meta-analysis
by: Yang Xue, et al.
Published: (2020-12-01) -
ACEIs and ARBs and Their Correlation with COVID-19: A Review
by: Yehualashet AS, et al.
Published: (2020-09-01) -
Comparing clinical outcomes of ARB and ACEi in patients hospitalized for acute COVID-19
by: Seiji Hamada, et al.
Published: (2023-07-01)